---
$id: https://graph.org.ai/products/commodity/51143008
$type: Product
source: UNSPSC
code: "51143008"
title: "Dimiracetam"
class: "51143000"
classTitle: "Nootropics"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Dimiracetam

**UNSPSC Code**: 51143008
**Class**: [Nootropics](Nootropics.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a neuroprotective agent with the molecular formula C6H8N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 4AW7F70MZO chemically known as (+/-)-dihydro-1h-pyrrolo(1,2-a)imidazole-2,5(3h,6h)-dione but generally known as dimiracetam, which bears US NIH Compound Identifier 65955. European Medicines Agency schedules Dimiracetam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07186MIG. The term DIMIRACETAM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 7, no3, 1993, list 33). Most nations schedule dimiracetam under HS 29337900 and SITC 51561. As of Q4 2014, DIMIRACETAM remains the US FDA Preferred Term for this commodity. Dimiracetam bears US NLM identifiers UMLS ID C0250359 and NCI Concept Code C79121. SMILES: C1CC(=O)N2C1NC(=O)C2.

